Johnson & Johnson (JNJ) vs Space Exploration Technologies Corp. Class A Common Stock (SPCX)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Space Exploration Technologies Corp., known as SpaceX, is an aerospace and satellite communications company founded by Elon Musk. The company designs, manufactures and launches reusable rockets and spacecraft, including the Falcon launch family, Dragon spacecraft and the Starship system under development. SpaceX also operates Starlink, a low Earth orbit satellite broadband network serving consumers, businesses, governments and mobility markets. Its business model combines launch services, satellite internet, defense and civil space contracts, and longer-term ambitions around fully reusable heavy-lift space transportation.